Prediction models for rectal toxicity after brachytherapy in patients with pelvic cancer

被引:0
|
作者
Tohidinezhad, F. [1 ]
Willems, Y. [1 ]
Berbee, M. [1 ]
Van Limbergen, E. [1 ]
Verhaegen, F. [1 ]
Dekker, A. [1 ]
Traverso, A. [1 ]
机构
[1] Maastricht Univ, Dept Radiat Oncol, Maastro Clin, Med Ctr, Maastricht, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0634
引用
收藏
页码:S565 / S566
页数:2
相关论文
共 50 条
  • [1] Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review
    Tohidinezhad, Fariba
    Willems, Yves
    Berbee, Maaike
    Van Limbergen, Evert
    Verhaegen, Frank
    Dekker, Andre
    Traverso, Alberto
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (04) : 411 - 422
  • [2] Does chemotherapy increase the pelvic toxicity of vaginal brachytherapy for endometrial cancer patients?
    Nieto, K.
    Martin, B.
    Palmere, L.
    Brennan, K.
    Pham, N.
    Albuquerque, K.
    Liotta, M.
    Small, W.
    Harkenrider, M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 187 - 188
  • [3] Local Pelvic Relapses after Neoadjuvant High-dose Rate Endorectal Brachytherapy for Patients with Operable Rectal Cancer
    Vuong, Te
    Niazi, Tamim
    Artho, Giovanni
    Richard, Carole
    Letellier, Francois
    Liberman, Sender
    Anderson, Dawn
    Morin, Nancy
    Devic, Slobodan
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (04) : 228 - 234
  • [4] Dosiomics models for prediction of skin toxicity after radiotherapy in breast cancer patients
    Beigi, Manijeh
    Soltani, Samira
    Bagherpour, Zahra
    Aliasgharzadeh, Akbar
    Fadavi, Pedram
    Jajroudi, Mahdie
    Khajetash, Benyamin
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S599 - S603
  • [5] Lyman-Kutcher-Burmanp Pelvic Radiation Dosimetric Prediction Model of Acute Hematologic Toxicity for Rectal Cancer Patients
    Wan, X.
    Fan, X.
    Cheng, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S215 - S215
  • [6] Evaluation of Toxicity in Patients With Metastatic and Recurrent Cervical Cancer Receiving Bevacizumab after Pelvic Radiation Therapy with HDR Brachytherapy
    DeMasi, J.
    Kumar, S.
    Feddock, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E288 - E289
  • [7] Evaluating dose parameters and toxicity in endoluminal brachytherapy for inoperable rectal cancer patients.
    Velema, L.
    Nout, R.
    Bakuwel, S.
    Neelis, K.
    Cats, A.
    Van Ruiten, I.
    Ketelaars, M.
    Marijnen, C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S73 - S74
  • [8] INVESTIGATION OF RECTAL AND BLADDER ACUTE TOXICITY AFTER EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY IN GYNECOLOGICAL CANCER
    Fiorentino, A.
    Chiumento, C.
    Lapadula, L.
    Castaldo, G.
    Pedicini, P.
    Califano, G.
    Stefania, C.
    Fusco, V.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S301 - S301
  • [9] Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study
    Rijkmans, Eva C.
    Marijnen, Corrie A. M.
    van Triest, Baukelien
    Ketelaars, Martijn
    Cats, Annemieke
    Inderson, Akin
    van den Ende, Roy P. J.
    Laman, Mirjam S.
    Kerkhof, Ellen M.
    Nout, Remi A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 176 - 182
  • [10] Understanding Quality of Life After Pelvic Exenteration for Patients with Rectal Cancer
    Brown, Kilian G. M.
    Solomon, Michael J.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 7668 - 7670